Clinical Trials Logo

Filter by:
NCT ID: NCT05881226 Recruiting - Biomarkers Clinical Trials

Application of Biomarkers in Neurological Diseases

Start date: June 5, 2023
Phase:
Study type: Observational [Patient Registry]

To explore the predictive and diagnostic role of biomarkers in patients with neurological diseases.

NCT ID: NCT05881109 Completed - Clinical trials for Invasive Fungal Infections

Population Pharmacokinetics and Dose Optimization of Caspofungin in Adolescents

Start date: January 1, 2018
Phase:
Study type: Observational

Caspofungin (CAS) is used to prevent and treat invasive fungal infections patients older than 3 months. However, the optimal dosing strategy of CAS is lacking in adolescents from 12 to 17 years old, especially those undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), who are vulnertable to fungal infections. The study aimed to establish a population pharmacokinetic (PPK) model and assess the dosing schemes of CAS in adolescents with allogeneic hematopoietic stem cell transplantation (allo-HSCT).

NCT ID: NCT05880927 Recruiting - Breast Cancer Clinical Trials

Pyrotinib After Trastuzumab-based Adjuvant Therapy in Patients With HER2-positive Breast Cancer

Start date: January 1, 2019
Phase: Phase 2
Study type: Interventional

This trial is a multicenter, open-label, phase II trial conducted at 23 centers in China. High-risk HER2 positive patients receive pyrotinib 400mg/day for one year or half year for extented adjuvant therapy.

NCT ID: NCT05880706 Recruiting - Clinical trials for Non-small Cell Lung Cancer

A Study of BL-B01D1 Combined With Osimertinib Mesylate Tablets in Patients With Non-small Cell Lung Cancer

Start date: July 19, 2023
Phase: Phase 2
Study type: Interventional

A Phase II clinical study to evaluate the efficacy and safety of BL-B01D1 for injection in combination with Osimertinib Mesylate Tablets in patients with locally advanced or metastatic non-small cell lung cancer with EGFR-sensitive mutations

NCT ID: NCT05880485 Active, not recruiting - Clinical trials for Uterine Cervical Neoplasm

Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer

Start date: February 2, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

Online adaptive radiotherapy (oART) has demonstrated to be feasible to reduce planning target volume (PTV) margins for cervical cancer. To explore the value of reduced margins in oART for cervical cancer, we conducted a prospective clinical trial to determine the clinical efficacy and toxicity of reduced margins.

NCT ID: NCT05880082 Enrolling by invitation - Clinical trials for Esophageal Squamous Cell Carcinoma

PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer

PPIO-004-EC001
Start date: April 13, 2023
Phase: Phase 2
Study type: Interventional

The goal of this observational study is to learn about in potential operable esophageal cancer patients (cT1-2N + M0 and cT3NanyM0) receiving neoadjuvant therapy. The main questions it aims to answer are: Objective response rate, Major pathological response rate. Participants will receive two to four cycles of tislelizumab plus albuminpaclitaxel and platinum-based therapy

NCT ID: NCT05879861 Recruiting - Colorectal Cancer Clinical Trials

Development and Validation of a Risk Prediction Model for Preoperative Frailty in Elderly Patients With Colorectal Cancer

Start date: August 1, 2022
Phase:
Study type: Observational

Fried Scale and its related scales were used to analyze the status and risk factors of preoperative frailty in elderly patients with colorectal cancer. R software was used to construct a risk prediction model for preoperative frailty in elderly patients with colorectal cancer, and its validity and stability were verified in clinical practice.

NCT ID: NCT05879822 Recruiting - Clinical trials for Advanced Solid Tumor

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

Start date: October 30, 2023
Phase: Phase 2
Study type: Interventional

This study is being conducted to determine the safety, tolerability, and preliminary efficacy of INCB099280 in participants with advanced solid tumors.

NCT ID: NCT05879783 Recruiting - Colorectal Cancer Clinical Trials

Optical Biopsy for Peritoneal Nodules in Colorectal Patients

Start date: September 15, 2022
Phase: N/A
Study type: Interventional

During surgery, peritoneal metastasis is typically confirmed pathologically through resection sample. However, this process can be time-consuming when utilizing intro-operative frozen section pathology. To address this issue, we propose utilizing confocal laser endomicroscopy to provide in situ, real-time, and in-vivo diagnosis of suspected peritoneal nodules as cancer metastasis during surgery.

NCT ID: NCT05879627 Recruiting - Clinical trials for Advanced Solid Tumors

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

Start date: January 17, 2023
Phase: Phase 1
Study type: Interventional

A multicenter, open phase I clinical study to evaluate the safety, tolerance and pharmacokinetics of BAT8007 for injection in patients with advanced solid tumors.